メタボロミクス：技術と世界市場

世界のメタボロミクスの市場規模は、2021年に127億米ドルとなりました。

同市場は、2021年～2026年にかけて12.3%のCAGRで拡大し、2026年には227億米ドルに達すると予測されています。

当レポートでは、メタボロミクスの世界市場について調査し、市場の概要とともに、製品別、適応別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

• 調査の目標と目的
• この調査を行う理由
• このレポートの新機能
• レポートの範囲
• 情報源
• 調査手法
• 地理的内訳
• アナリストの経歴
• BCCカスタム調査
• 関連するBCC調査レポート

第2章 まとめとハイライト

• メタボロミクス市場のハイライト

第3章 メタボロミクスの概要

• イントロダクション
• 代謝物
• メタボロミクス
• メタボロミクスの歴史
• 代謝経路
• メタボローム
• 大腸ミクロフローラ
• 尿メタボローム
• 食品メタボローム
• リピドームとリピドーム
• フラクソミクス
• メタボロミクスプロセスステップ
• サンプル調製
• 抽出
• 誘導体化
• 分離と検出
• データ分析
• メタボロミクステクノロジー
• 標的アプローチと非標的アプローチ
• 用途

第4章 メタボロミクス：パイプライン分析

• 概要

第5章 メタボロミクス：市場力学

• メタボロミクス市場の促進要因
• メタボロミクス研究への投資拡大
• 個別化医療の需要拡大
• 製薬およびバイオテクノロジーの研究開発費の増加
• 技術の進歩
• 毒物学試験におけるメタボロミクスの使用の増加
• 市場の抑制要因
• データの検証と処理に関連する複雑さ
• ツールと機器の高コスト
• 熟練した研究者の不足
• 業界考察
• 市場動向

第6章 COVID-19パンデミックの影響

• イントロダクション
• アウトブレイク
• メタボロミクスに対するCOVID-19の影響

第7章 メタボロミクスの世界市場の内訳、製品別

• イントロダクション
• 分離技術
• クロマトグラフィ
• 検出技術
• 質量分析
• 分光法
• アッセイ
• バイオインフォマティクスとシステム生物学ツール

第8章 メタボロミクスの世界市場の内訳、適応別

• イントロダクション
• 市場の内訳
• 癌
• 心血管疾患
• 神経学的疾患
• 先天性代謝異常症

第9章 メタボロミクスの世界市場の内訳、用途別

• イントロダクション
• バイオマーカー探索
• 創薬
• 毒性試験
• ニュートリゲノミクス
• 機能ゲノミクス

第10章 メタボロミクスの世界市場の内訳、地域別

• イントロダクション
• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• ドイツ
• 英国
• フランス
• イタリア
• スペイン
• その他
• アジア太平洋
• 日本
• 中国
• インド
• その他
• ラテンアメリカ
• 中東・アフリカ（MEA）

第11章 競合情勢

• 世界の企業シェア分析
• 合併と買収
• 契約、コラボレーション、製品発売、およびパートナーシップ

第12章 企業プロファイル

• AGILENT TECHNOLOGIES INC.
• BIOCRATES LIFE SCIENCES AG
• BIO-RAD LABORATORIES INC.
• BIOVISION INC.
• BRUKER CORP.
• CHENOMX
• DANAHER CORP.
• DRUMETIX LABORATORIES LLC
• GERSTEL GMBH & CO. KG
• HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
• LECO CORP.
• MERCK KGAA
• METABOLOMIC DIAGNOSTICS
• METABOLOMIC TECHNOLOGIES INC.
• METABOLON INC.
• ONE WAY LIVER GENOMICS S.L.
• PERKINELMER INC.
• PROMEGA CORP.
• QIAGEN N.V.
• SHIMADZU CORP.
• STEMINA BIOMARKER DISCOVERY INC.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Metabolomics, by Product Type, Through 2026
• Table 1 : Publications Referencing Metabolomics, 2008-2018
• Table 2 : Major Approaches in Metabolomics and their Advantages and Disadvantages
• Table 3 : Some Pipeline Clinical Trial Studies for Metabolomics
• Table 4 : Recent Funding Programs in Metabolomics
• Table 5 : Common Hyphenated Platforms in Metabolomic Research
• Table 6 : Global Market for Metabolomics, by Product Type, Through 2026
• Table 7 : Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 8 : Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 9 : Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 10 : Mass Spectroscopy Suppliers for the Life Sciences
• Table 11 : Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 12 : High-Content Screening Suppliers and Key Attributes
• Table 13 : Assays Commonly Used with Metabolomic Assays
• Table 14 : Metabolomic Public Resources
• Table 15 : Global Market for Metabolomics, by Indication, Through 2026
• Table 16 : Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
• Table 17 : Global Market for Metabolomics, by Application, Through 2026
• Table 18 : Global Market for Metabolomics, by Region, Through 2026
• Table 19 : North American Market for Metabolomics, by Product Type, Through 2026
• Table 20 : North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 21 : North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 22 : North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 23 : North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 24 : North American Market for Metabolomic Assays, by Product Type, Through 2026
• Table 25 : North American Market for Metabolomics, by Indication, Through 2026
• Table 26 : North American Market for Metabolomics, by Application, Through 2026
• Table 27 : European Market for Metabolomics, by Product Type, Through 2026
• Table 28 : European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 29 : European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 30 : European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 31 : European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 32 : European Market for Metabolomic Assays, by Product Type, Through 2026
• Table 33 : European Market for Metabolomics, by Indication, Through 2026
• Table 34 : European Market for Metabolomics, by Application, Through 2026
• Table 35 : Asia-Pacific Market for Metabolomics, by Product Type, Through 2026
• Table 36 : Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 37 : Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 38 : Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 39 : Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 40 : Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2026
• Table 41 : Asia-Pacific Market for Metabolomics, by Indication, Through 2026
• Table 42 : Asia-Pacific Market for Metabolomics, by Application, Through 2026
• Table 43 : Latin American Market for Metabolomics, by Product Type, Through 2026
• Table 44 : Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 45 : Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 46 : Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 47 : Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 48 : Latin American Market for Metabolomic Assays, by Product Type, Through 2026
• Table 49 : Latin American Market for Metabolomics, by Indication, Through 2026
• Table 50 : Latin American Market for Metabolomics, by Application, Through 2026
• Table 51 : Middle Eastern and African Market for Metabolomics, by Product Type, Through 2026
• Table 52 : Middle Eastern and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 53 : Middle Eastern and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
• Table 54 : Middle Eastern and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
• Table 55 : Middle Eastern and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
• Table 56 : Middle Eastern and African Market for Metabolomic Assays, by Product Type, Through 2026
• Table 57 : Middle Eastern and African Market for Metabolomics, by Indication, Through 2026
• Table 58 : Middle Eastern and African Market for Metabolomics, by Application, Through 2026

List of Figures

• Summary Figure : Global Market for Metabolomics, by Product Type, 2020-2026
• Figure 1 : Publications Referencing Metabolomics, 2008-2018
• Figure 2 : Cellular Respiration Stages
• Figure 3 : Factors Impacting Enzyme Activity
• Figure 4 : Typical Analytical Metabolomic Process Steps
• Figure 5 : Schematic Representation of a Metabolomic Workflow
• Figure 6 : Bioinformatic Processes for Metabolomics
• Figure 7 : Global Market for Metabolomics, by Region, 2020
• Figure 8 : Global Metabolomics Market Share Analysis, by Company, 2020
• Figure 9 : Agilent: Annual Revenue, 2018-2020
• Figure 10 : Agilent: Revenue Share, by Geography, 2020
• Figure 11 : Agilent: Revenue Share, by Segment, 2020
• Figure 12 : Bio-Rad: Annual Revenue, 2018-2020
• Figure 13 : Bio-Rad: Revenue Share, by Segment, 2020
• Figure 14 : Bruker: Annual Revenue, 2018-2020
• Figure 15 : Bruker: Revenue Share, by Region, 2020
• Figure 16 : Danaher Corp.: Annual Revenue, 2018-2020
• Figure 17 : Danaher Corp.: Revenue Share, by Geography, 2020
• Figure 18 : Danaher Corp.: Revenue Share, by Segment, 2020
• Figure 19 : Merck KGaA: Annual Revenue, 2019 and 2020
• Figure 20 : Merck KGaA: Revenue Share, by Region, 2020
• Figure 21 : Merck KGaA: Revenue Share, by Segment, 2020
• Figure 22 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
• Figure 23 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020

Highlights:

The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.

The separation techniques segment of the global metabolomics market is expected to grow from $5.1 billion in 2021 to $8.7 billion in 2026 at a CAGR of 11.3% for the forecast period of 2021 to 2026.

The detection techniques segment of the global metabolomics market is expected to grow from $4.0 billion in 2021 to $7.1 billion in 2026 at a CAGR of 12.4% for the forecast period of 2021 to 2026.

Report Scope:

This report examines the current and forecasted market potential for metabolomics. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for metabolomics based on product, indication and application type.

By product, the metabolomics market is segmented into separation techniques, detection techniques, assays, and bioinformatics. By indication type, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The others segment covers respiratory diseases, infectious diseases, etc. By application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and others.

By geography, the metabolomics market has been segmented into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are found in the regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on metabolomics companies' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

• 59 tables
• An overview and industry analysis of the global markets for metabolomics technologies
• Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
• Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
• Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
• Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
• Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
• Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
• Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Report
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

• Highlights of the Market for Metabolomics

Chapter 3 Overview of Metabolomics

• Introduction
• Metabolites
• Metabolomics
• Metabolomic History
• Metabolic Pathways
• Metabolomes
• Large Bowel Microflora
• Urine Metabolome
• Food Metabolome
• Lipidomes and Lipidomics
• Fluxomics
• Metabolomic Process Steps
• Sample Preparation
• Extraction
• Derivatization
• Separation and Detection
• Data Analysis
• Metabolomic Technology
• Targeted and Untargeted Approaches
• Applications

Chapter 4 Metabolomics: Pipeline Analysis

• Overview

Chapter 5 Metabolomics: Market Dynamics

• Metabolomics Market Drivers
• Increasing Investment in Metabolomic Research
• Increase in Demand for Personalized Medicine
• Increasing Pharmaceutical and Biotech R&D Spending
• Technological Advancements
• Increasing Use of Metabolomics in Toxicology Testing
• Market Restraints
• Complexity Associated with Data Examination and Processing
• High Cost of Tools and Instruments
• Dearth of Skilled Researchers
• Industry Insights
• Market Trends

Chapter 6 Impact of COVID-19 Pandemic

• Introduction
• Outbreak
• Impact of COVID-19 on Metabolomics

Chapter 7 Global Metabolomics Market Breakdown by Product

• Introduction
• Separation Techniques
• Chromatography
• Detection Techniques
• Mass Spectrometry
• Spectroscopy
• Assays
• Bioinformatics and Systems Biology Tools

Chapter 8 Global Metabolomics Market Breakdown by Indication

• Introduction
• Market Breakdown
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism

Chapter 9 Global Metabolomics Market Breakdown by Application

• Introduction
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics

Chapter 10 Global Metabolomics Market Breakdown by Region

• Introduction
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Rest of Asia-Pacific
• Latin America
• Middle East and Africa (MEA)

Chapter 11 Competitive Landscape

• Global Company Share Analysis
• Mergers and Acquisitions
• Agreements, Collaborations, Product Launches, and Partnerships

Chapter 12 Company Profiles

• AGILENT TECHNOLOGIES INC.
• BIOCRATES LIFE SCIENCES AG
• BIO-RAD LABORATORIES INC.
• BIOVISION INC.
• BRUKER CORP.
• CHENOMX
• DANAHER CORP.
• DRUMETIX LABORATORIES LLC
• GERSTEL GMBH & CO. KG
• HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
• LECO CORP.
• MERCK KGAA
• METABOLOMIC DIAGNOSTICS
• METABOLOMIC TECHNOLOGIES INC.
• METABOLON INC.
• ONE WAY LIVER GENOMICS S.L.
• PERKINELMER INC.
• PROMEGA CORP.
• QIAGEN N.V.
• SHIMADZU CORP.
• STEMINA BIOMARKER DISCOVERY INC.
• THERMO FISHER SCIENTIFIC INC.